PowelH.BrownMD

PubMed

• IRX4204 Induces Senescence and Cell Death in HER2-positive Breast Cancer and Synergizes with Anti-HER2 Therapy.
  Cassandra L Moyer, Amanda Lanier, Jing Qian, Darian Coleman, Jamal Hill, Vidyasagar Vuligonda, Martin E Sanders, Abhijit Mazumdar, Powel H Brown> ;Clinical Cancer Research. 2024 Apr 5
• Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
  Jing Qian, Yanxia Ma, William M Tahaney, Cassandra L Moyer, Amanda Lanier, Jamal Hill, Darian Coleman, Negar Koupaei, Susan G Hilsenbeck, Michelle I Savage, Brent D G ...> ;Breast Cancer Research. 2024 Mar 26
• 1 citations
  The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth.
  Jing Qian, Yanxia Ma, William M Tahaney, Cassandra L Moyer, Amanda Lanier, Jamal Hill, Darian Coleman, Negar Koupaei, Susan G Hilsenbeck, Michelle I Savage, Brent D G ...> ;Breast Cancer Research. 2024 Feb 5
• Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
  Johansson, H., Guerrieri-Gonzaga, A., Gandini, S., Bertelsen, B., Macis, D., Serrano, D., Mellgren, G., Lazzeroni, M., Thomas, P., Crew, K., Kumar, N., Briata, I., Gal...> ;NPJ Breast Cancer. 2024 Jan 18
• 1 citations
  Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
  Anne E O'Shea, Guy T Clifton, Na Qiao, Brandy M Heckman-Stoddard, Malgorzata Wojtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E Garber, Alexander Husban...> ;Cancer Prevention Research. 2023 Jun 1
• Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
  Anne E O'Shea, Guy T Clifton, Na Qiao, Brandy M Heckman-Stoddard, Malgorzata Wojtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E Garber, Alexander Husban...> ;Cancer Prevention Research. 2023 May 8
• Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma in Situ.
  Anne E O'Shea, Guy T Clifton, Na Qiao, Brandy M Heckman-Stoddard, Malgorzata Wojtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E Garber, Alexander Husban...> ;Cancer Prevention Research. 2023 Apr 26
• 3 citations
  Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial.
  Davide Serrano, Sara Gandini, Parjhitham Thomas, Katherine D Crew, Nagi B Kumar, Lana A Vornik, J Jack Lee, Paolo Veronesi, Giuseppe Viale, Aliana Guerrieri-Gonzaga, M...> ;JAMA Oncology. 2023 May 1
• 7 citations
  CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
  Erika Y Faraoni, Kanchan Singh, Vidhi Chandra, Olivereen Le Roux, Yulin Dai, Ismet Sahin, Baylee J O'Brien, Lincoln N Strickland, Le Li, Emily Vucic, Amanda N Warner, ...> ;Cancer Research. 2023 Apr 4
• 1 citations
  Targeting nuclear hormone receptors for the prevention of breast cancer.
  Cassandra L Moyer, Powel H Brown> ;Frontiers in Medicine. 2023 Jan 1
• Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa.
  Charles M Bowen, Nan Deng, Laura Reyes-Uribe, Edwin Roger Parra, Pedro Rocha, Luisa M Solis, Ignacio I Wistuba, Valerie O Sepeda, Lana Vornik, Marjorie Perloff, Eva Sz...> ;Frontiers in Immunology. 2023 Jan 1
• 2 citations
  Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.
  Parijatham S Thomas, Anisha B Patel, J Jack Lee, Diane D Liu, Mike Hernandez, Miguel Muzzio, Alejandro Contreras, Valerie Sepeda, Carrie Mays, Diane Weber, Lana A Vorn...> ;Cancer Prevention Research. 2023 Jan 4
• 2 citations
  Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor.
  Suet-Ying Kwan, Alyssa N Slayden, Aubrey R Coronado, Rosamaria C Marquez, Huiqin Chen, Peng Wei, Michelle I Savage, Lana A Vornik, Jennifer T Fox, Shizuko Sei, Dong Li...> ;Cancer Prevention Research. 2023 Jan 4
• 1 citations
  Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy.
  Meghna S Trivedi, Nadir Arber, Eitan Friedman, Judy E Garber, Kevin Holcomb, Neil S Horowitz, Jason D Wright, J Jack Lee, Lana A Vornik, Saba Abutaseh, Tawana Castile,...> ;Cancer Prevention Research. 2022 Nov 1
• 3 citations
  Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer.
  Abhijit Mazumdar, William M Tahaney, Jamal L Hill, Yun Zhang, Sumankalai Ramachandran, Jitesh Kawedia, Jing Qian, Alejandro Contreras, Michelle I Savage, Lana A Vornik...> ;Cancer Prevention Research. 2022 Dec 1
• 25 citations
  Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
  Shaolong Cao, Jennifer R Wang, Shuangxi Ji, Peng Yang, Yaoyi Dai, Shuai Guo, Matthew D Montierth, John Paul Shen, Xiao Zhao, Jingxiao Chen, Jaewon James Lee, Paola A G...> ;Nature Biotechnology. 2022 Nov 1
• 2 citations
  Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial.
  , , , , , , , , , , , , , , , , , > ;Contemporary Clinical Trials. 2021 Jun 30
• 2 citations
  Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.
  Mark Steven Miller, Peter J. Allen, Powel H. Brown, Andrew T. Chan, Margie L. Clapper, Roderick H. Dashwood, Shadmehr Demehri, Mary L. Disis, Raymond N. DuBois, Robert...> ;Journal of Cancer Prevention. 2021 Mar 30
• Response to Braillon.
  Bernardo Bonanni, Davide Serrano, Patrick Maisonneuve, Matteo Lazzeroni, Powel H. Brown, Aliana Guerrieri-Gonzaga, Eva Szabo> ;JNCI Cancer Spectrum. 2021 Jan 23
• 9 citations
  Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
  Ahmet M. Ulusan, Praveen Rajendran, Wan Mohaiza Dashwood, Omer F. Yavuz, Sabeeta Kapoor, Trace A. Gustafson, Michelle I. Savage, Powel H. Brown, Shizuko Sei, Altaf Moh...> ;Cancer Prevention Research. 2021 Mar 1
• 2 citations
  Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial
  Bernardo Bonanni, Davide Serrano, Patrick Maisonneuve, Giulia Veronesi, Harriet Johansson, Valentina Aristarco, Clara Varricchio, Massimiliano Cazzaniga, Matteo Lazzer...> ;JNCI Cancer Spectrum. 2020 Oct 20
• 33 citations
  SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis.
  Yanxia Ma, Jonathan Shepherd, Dekuang Zhao, Lakshmi Reddy Bollu, William M. Tahaney, Jamal Hill, Yun Zhang, Abhijit Mazumdar, Powel H. Brown> ;Molecular Cancer Research. 2020 Jul 13
• 24 citations
  Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa
  Laura Reyes-Uribe, Wenhui Wu, Ozkan Gelincik, Prashant V. Bommi, Alejandro Francisco-Cruz, Luisa M. Solis, Patrick M. Lynch, R. Lim, Elena M. Stoffel, Priyanka Kanth, ...> ;Gut. 2021 Mar 1
• 2 citations
  Erratum: PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma (Science Translational Medicine DOI: 10.1016/j.bbcan.2016.06.002)
  Xiaochao Tan, Priyam Banerjee, Florentine U. Rutaganira, Basu Kaustabh, Neus Bota-Rabassedas, Hou Fu Guo, Caitlin L. Grzeskowiak, Xi Liu, Jiang Yu, Lei Shi, David H. P...> ;Science Translational Medicine. 2020 Mar 18
• 42 citations
  TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
  Benjamin C. Chandler, Leah Moubadder, Cassandra L. Ritter, Meilan Liu, Meleah Cameron, Kari Wilder-Romans, Amanda Zhang, Andrea M. Pesch, Anna R. Michmerhuizen, Nicole...> ;The Journal of Clinical Investigation. 2020 Feb 3
• Join now to see all